MedPath

The Impact of Riboflavin on Sports-related Concussion

Phase 2
Conditions
Sports-related Concussion
Registration Number
NCT02772237
Lead Sponsor
University of Virginia
Brief Summary

The purpose of this study is to investigate the effectiveness of riboflavin to decrease the duration of time for a student-athlete to return to participation in sports after a sports related concussion.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
500
Inclusion Criteria
  • All UVa and JMU student-athletes over the age of 18 years old who are diagnosed with a sports related concussion
Exclusion Criteria
  • Less than 18 years old
  • Greater than 24 hours have elapsed since the concussion occurred.
  • The student-athlete has already participated in the study during which he/she took Riboflavin
  • Non-sports related concussion not incurred while participating in the sport or training for the sport. As an example, a student-athlete who sustains a concussion as a result of a motor vehicle accident will be excluded from the study for that concussion.
  • A previous concussion within the last 12 months.
  • Any concussion that is complicated by a cranial bleed, skull fracture, additional severe injury (e.g. torn knee ligament) that might affect the return to normal activities above and beyond the sport-related concussion.
  • If the student athlete is cognitively impaired to a level that prevents verbal communication, the consent will be deemed 'opted out' and the student-athlete will not be enrolled in the study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Time to return to participation in sports after a sports-related concussion14 days
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Virginia

πŸ‡ΊπŸ‡Έ

Charlottesville, Virginia, United States

University of Virginia
πŸ‡ΊπŸ‡ΈCharlottesville, Virginia, United States
Jeremy B Kent
Contact

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.